Epigral Ltd. Investor Presentation

Epigral Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter

Conference/Earnings Calls Alerts

Epigral Ltd.

15 Nov 2021

1784.60

0.21%

Investor Presentation

Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Meghmani Finechem Limited forward herewith Corporate Presentation of the Company. The aforesaid information is also being placed on the website of the Company at www.meghmanifinechem.com.

pdf

Epigral Ltd.

11 Nov 2021

1784.60

0.21%

Investor Presentation

Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are enclosing herewith a copy of Corporate Announcement Presentation of the Company for information of members. The above presentation is also being placed on the website of the Company at www.meghmanifinechem.com.

pdf

Epigral Ltd.

26 Oct 2021

1784.60

0.21%

Investor Presentation

Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Meghmani submits Q-2 FY22 Earnings Presentation.

pdf

Epigral Ltd.

20 Aug 2021

1784.60

0.21%

Investor Presentation

Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We forward herewith the Corporate Presentation of the Company. The presentation will be shared to Investors for Virtual Conference/Investors Meet/Conference Call.

pdf

Epigral Ltd.

18 Aug 2021

1784.60

0.21%

Investor Presentation

Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

MFL forwards herewith the Earnings Presentation of Q 1 F. Y. 2022 for information of the Members.

pdf